Literature DB >> 9056264

Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase.

W J Arion1, W K Canfield, F C Ramos, P W Schindler, H J Burger, H Hemmerle, G Schubert, P Below, A W Herling.   

Abstract

We have studied the interactions of chlorogenic acid (CHL) and 2-hydroxy-5-nitrobenzaldehyde (HNB) with the components of the rat hepatic glucose 6-phosphatase (Glc-6-Pase) system. CHL and HNB are competitive inhibitors of glucose 6-phosphate (Glc-6-P) hydrolysis in intact microsomes with Ki values of 0.26 and 0.22 mm, respectively. CHL is without effect on the enzyme of fully disrupted microsomes or the system inorganic pyrophosphatase (PPiase) activity. HNB is a potent competitive inhibitor of the system PPiase activity (Ki = 0.56 mm) and a somewhat weaker noncompetitive inhibitor of enzyme activity (Ki = 2.1 mm). These findings indicate CHL binds to T1, the Glc-6-P transporter, and HNB inhibits through interaction with both T1 and T2 the phosphate (Pi)-PPi transporter. Binding of CHL and HNB is freely reversible. However, the inhibition of both PPiase and Glc-6-Pase by HNB becomes irreversible following incubation of HNB-exposed microsomes with 2.5 mm sodium borohydride, indicating that inhibition involves the formation of a Schiff base. The presence of CHL effectively protects T1, but not T2, against the irreversible inhibition by HNB. In contrast, PPi and Pi are effective in protecting T2, but not T1. This is the first report describing an effective inhibitor of the system PPiase activity (T2). CHL is the most specific T1 inhibitor described to date.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9056264     DOI: 10.1006/abbi.1996.9874

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  51 in total

1.  Association of coffee drinking with total and cause-specific mortality.

Authors:  Neal D Freedman; Yikyung Park; Christian C Abnet; Albert R Hollenbeck; Rashmi Sinha
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

2.  Coffee consumption and the incidence of type 2 diabetes in men and women with normal glucose tolerance: the Strong Heart Study.

Authors:  Y Zhang; E T Lee; L D Cowan; R R Fabsitz; B V Howard
Journal:  Nutr Metab Cardiovasc Dis       Date:  2010-02-18       Impact factor: 4.222

3.  Identification of protein components of the microsomal glucose 6-phosphate transporter by photoaffinity labelling.

Authors:  W Kramer; H J Burger; W J Arion; D Corsiero; F Girbig; C Weyland; H Hemmerle; S Petry; P Habermann; A Herling
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

4.  Coffee Consumption and Incident Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Emily A Hu; Elizabeth Selvin; Morgan E Grams; Lyn M Steffen; Josef Coresh; Casey M Rebholz
Journal:  Am J Kidney Dis       Date:  2018-03-20       Impact factor: 8.860

Review 5.  Dysregulation of metabolic enzymes in tumor and stromal cells: Role in oncogenesis and therapeutic opportunities.

Authors:  Mohammad Aslam Khan; Haseeb Zubair; Shashi Anand; Sanjeev Kumar Srivastava; Seema Singh; Ajay Pratap Singh
Journal:  Cancer Lett       Date:  2020-01-07       Impact factor: 8.679

6.  Coffee consumption and risk of incident gout in women: the Nurses' Health Study.

Authors:  Hyon K Choi; Gary Curhan
Journal:  Am J Clin Nutr       Date:  2010-08-25       Impact factor: 7.045

Review 7.  The Emerging Health Benefits of Coffee with an Emphasis on Type 2 Diabetes and Cardiovascular Disease.

Authors:  Siamak Bidel; Jaakko Tuomilehto
Journal:  Eur Endocrinol       Date:  2013-08-23

8.  Association of Coffee Consumption With Total and Cause-Specific Mortality in 3 Large Prospective Cohorts.

Authors:  Ming Ding; Ambika Satija; Shilpa N Bhupathiraju; Yang Hu; Qi Sun; Jiali Han; Esther Lopez-Garcia; Walter Willett; Rob M van Dam; Frank B Hu
Journal:  Circulation       Date:  2015-11-16       Impact factor: 29.690

9.  Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study.

Authors:  Catherine J Williams; Jessica L Fargnoli; Janice J Hwang; Rob M van Dam; George L Blackburn; Frank B Hu; Christos S Mantzoros
Journal:  Diabetes Care       Date:  2007-12-10       Impact factor: 19.112

10.  Does long-term coffee intake reduce type 2 diabetes mellitus risk?

Authors:  Gustavo D Pimentel; Juliane Cs Zemdegs; Joyce A Theodoro; João F Mota
Journal:  Diabetol Metab Syndr       Date:  2009-09-16       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.